MIL:1CRL'
s Pretax Margin % Range Over the Past 10 Years
Min: -4.11 Med: 13.42 Max: 15.99
Current: -4.11
MIL:1CRL's Pretax Margin % is ranked worse than 51.23% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.56
vs MIL:1CRL: -4.11
Charles River Laboratories International (MIL:1CRL) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Charles River Laboratories International Pretax Margin % Related Terms
Charles River Laboratories International Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Pretax Margin % Chart
Charles River Laboratories International Annual Data
MIL:1CRL vs RVTY, QGEN, ICLR: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a Pretax Margin % of -3.01% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Charles River Laboratories International and its competitors. According to the industry distribution chart, Charles River Laboratories International ranks #104 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 51.2%.
Is Charles River Laboratories International's Pretax Margin % too high?
Charles River Laboratories International's current Pretax Margin % is -3.01%. Based on the distribution chart, Charles River Laboratories International ranks #104 out of 203 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Pretax Margin % compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #104 out of 203 companies for Pretax Margin %. This places Charles River Laboratories International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Pretax Margin % is -3.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Pretax Margin % of -3.01%. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Pretax Margin % is -3.01%. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Pretax Margin % is -3.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.
Key valuation signals for MIL:1CRL:
Pretax Margin %: -3.01%
GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score
Get the complete analysis for MIL:1CRL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
